ANDO GORAN 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Jun 23, 2021
Insider Transaction Report
Form 4
ANDO GORAN
Director
Transactions
- Award
Restricted Stock Units
2021-06-22+2,750→ 2,750 totalExercise: $0.00From: 2022-02-09→ Common Stock (2,750 underlying) - Award
Stock Option (Right to Buy)
2021-06-22+12,000→ 12,000 totalExercise: $13.13From: 2022-02-09Exp: 2031-02-09→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]Will fully vest on the one-year anniversary of the grant date.